Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181156-04-000001
Filing Date
2004-11-17
Accepted
2004-11-17 16:44:51
Documents
1
Period of Report
2004-11-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3952
  Complete submission text file 0001181156-04-000001.txt   5770
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Issuer) CIK: 0001003124 (see all company filings)

EIN.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address
Business Address PHARMACEUTICAL PRODUCT DEVELOPMENT INC 3151 S 17TH ST WILMINGTON DE 28412 9102510081
HARTMAN JUDD (Reporting) CIK: 0001181156 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27570 | Film No.: 041152604